Capmatinib is a specialized inhibitor that targets the MET kinase, which is important for MET exon 14 skipping mutations in advanced lung cancer. You’ve got two options: 150 mg or 200 mg tablets, both with a film coating.
You’re supposed to take 400 mg of the stuff two times a day, whether you eat or not. These pills come in bottles with 60 tablets in each one.
